The objective of this study was to evaluate the antitumor
activity of DHMEQ as monotherapy
Bogdanov, A.V.,
Ivanova, A.A.,
Voloshina, A.D.,
Rakhmatullin, R.R.,
Samorodov, A.V.,
Valiullina, Z.A.,
Krylova, I.D.,
Bukharov, S.V. (2024) ). The resulting compounds were shown to have high antitumor
activity against duodenal adenocarcinoma (HuTu80
group of phytochemicals with potent
antioxidant and anti-inflammatory properties, in modulating nc
Klen, E.E.,
Nikitina, I.L.,
Khaliullin, F.A.,
Shepilova, S.O.,
Nikitina, E.A.,
Gaisina, G.G.,
Samorodov, A.V.,
Pavlov, V.N. (2024) bioavailability. The compounds exhibited varying degrees of antidepressant
activity after a single intraperitoneal